Volume 393, Issue 1 p. 101-104
Research letter
Free Access

Activation of a recombinant membrane type 1‐matrix metalloproteinase (MT1‐MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)‐2

Hiroshi Sato

Department of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, 13-1 Takaramachi, Kanazawa 920, Japan

Search for more papers by this author
Takeshi Kinoshita

Department of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, 13-1 Takaramachi, Kanazawa 920, Japan

Search for more papers by this author
Takahisa Takino

Department of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, 13-1 Takaramachi, Kanazawa 920, Japan

Search for more papers by this author
Kazuo Nakayama

Institute of Biological Sciences and Gene Experiment Center, University of Tsukuba, Tsukuba 305, Japan

Search for more papers by this author
Motoharu Seiki

Department of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, 13-1 Takaramachi, Kanazawa 920, Japan

Search for more papers by this author
First published: September 09, 1996
Citations: 203
Corresponding author. Fax: (81) 762-60-7840.

Abstract

Membrane type 1‐matrix metalloproteinase (MT1‐MMP) initiates the activation of the zymogen progelatinase A/72‐kDa type IV collagenase by cleavage of the Asn66‐Leu peptide bond. We previously pointed out that MT1‐MMP possesses a unique amino acid sequence Arg‐Arg‐Lys‐Arg111 which is a potential recognition sequence for furin‐like proteases (Nature, 370 (1994) 61–65). Here, using a recombinant MT1‐MMP expressed in Escherichia coli we demonstrated that furin specifically cleaves MT1‐MMP between Arg111‐Tyr in vitro, which resulted in a stimulation of progelatinase A‐activation function. Tissue inhibitor of metalloproteinases (TIMP)‐2 inhibited activation of progelatinase A by forming a stable complex with activated MT1‐MMP.